List of SBIR/STTR awards granted to VenatoRx Pharmaceuticals

List of SBIR/STTR awards granted to VenatoRx Pharmaceuticals

List of SBIR/STTR awards granted to KIGRE, INC.

List of SBIR/STTR awards granted to Advanced Energy Materials

List of SBIR/STTR awards granted to Mgenuity Corporation

List of companies in Kathryn (Katie) Haun's investment portfolio

List of Techshot, Inc. patents

where

SBIR/STTR Award Recipient

is

VenatoRx Pharmaceuticals

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, May 2021	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in May, 2021 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	VenatoRx Pharmaceuticals		National Institutes of Health	SBIR	1R44AI155308-01A1	Phase II	1,000,000	May 24, 2021	sbir.gov/node/2188713
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, December 2020	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in December, 2020 for $252,813.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	VenatoRx Pharmaceuticals		National Institutes of Health	SBIR	1R43AI157533-01	Phase I	252,813	December 15, 2020	sbir.gov/node/2185597
	‌ VENATORX PHARMACEUTICALS INC SBIR Phase II Award, March 2022	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in March, 2022 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	VenatoRx Pharmaceuticals		National Institutes of Health	SBIR	1R44AI170331-01	Phase II	1,000,000	March 10, 2022	sbir.gov/node/2338661
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, May 2019	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in May, 2019 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	VenatoRx Pharmaceuticals		National Institutes of Health	SBIR	2R44AI118115-03	Phase II	1,000,000	May 15, 2019	sbir.gov/node/1681725
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, February 2018	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in February, 2018 for $2,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	VenatoRx Pharmaceuticals		National Institutes of Health	SBIR	2R44AI120392-03A1	Phase II	2,000,000	February 7, 2018	sbir.gov/node/1566661
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, July 2020	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in July, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	VenatoRx Pharmaceuticals		National Institutes of Health	SBIR	1R43AI152672-01	Phase I	300,000	July 15, 2020	sbir.gov/node/1911575
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, July 2016	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in July, 2016 for $3,462,890.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	1R44AI122421-01	Phase II	3,462,890	July 5, 2016	sbir.gov/node/1198425
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, July 2016	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in July, 2016 for $690,598.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	1R43AI124925-01A1	Phase I	690,598	July 2, 2016	sbir.gov/node/1196549
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, March 2015	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in March, 2015 for $600,000.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	1R43AI118115-01	Phase I	600,000	March 1, 2015	sbir.gov/node/1029205
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, June 2014	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in June, 2014 for $599,200.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	1R43AI109879-01	Phase I	599,200	June 1, 2014	sbir.gov/node/1029413
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, August 2017	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in August, 2017 for $3,000,000.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	2R44AI109879-03A1	Phase II	3,000,000	August 7, 2017	sbir.gov/node/1323729
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, September 2013	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in September, 2013 for $3,000,000.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	2R44AI096613-03A1	Phase II	3,000,000	September 1, 2013	sbir.gov/node/1031605
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, March 2017	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in March, 2017 for $599,998.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	1R43AI129009-01	Phase I	599,998	March 15, 2017	sbir.gov/node/1246461
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase II Award, August 2013	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in August, 2013 for $3,000,000.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	2R44AI096679-03	Phase II	3,000,000	August 1, 2013	sbir.gov/node/1031485
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award, June 2015	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in June, 2015 for $600,000.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	1R43AI120392-01	Phase I	600,000	June 15, 2015	sbir.gov/node/1029267
	‌ VenatoRx Pharmaceuticals, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals for $600,000.0 USD from the U.S. Department of Health & Human Services.	VenatoRx Pharmaceuticals			SBIR	1R43AI096679-01	Phase I	600,000		sbir.gov/content/preserving-beta-lactam-utility-against-pathogens-producing-all-classes-beta-la
	‌ VENATORX PHARMACEUTICALS INC SBIR Phase I Award, July 2023	A SBIR Phase I contract was awarded to VenatoRx Pharmaceuticals in July, 2023 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	VenatoRx Pharmaceuticals		National Institutes of Health	SBIR	1R43AI179443-01	Phase I	300,000	July 24, 2023	sbir.gov/node/2512615
	‌ VENATORX PHARMACEUTICALS INC SBIR Phase II Award, June 2023	A SBIR Phase II contract was awarded to VenatoRx Pharmaceuticals in June, 2023 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	VenatoRx Pharmaceuticals		National Institutes of Health	SBIR	1R44AI177015-01	Phase II	1,000,000	June 7, 2023	sbir.gov/node/2510083

18 results

0 selected

18 results

0 selected